We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Test Diagnoses Malaria in Returning Travelers

By LabMedica International staff writers
Posted on 07 Feb 2013
Print article
A novel, single-amplification polymerase chain reaction (PCR) assay has been used to diagnose malaria among travelers returning from endemic areas.

A practical single-round amplification Plasmodium-genus-specific PCR assays has been designed that is based on primers targeting the 18S locus and the mitochondrial genome with sensitivity and specificity equal to nested PCR.

Tropical disease specialists at the Haukeland University Hospital (Bergen, Norway) carried out a retrospective study of whole blood samples from a cohort of 132 fever patients with potential imported primary or recurrent malaria between 2006 and 2011. The samples had been previously analyzed for malaria parasites on Giemsa-stained, thin and thick slides by experienced microscopists. Three PCR assays, two genus-specific and one species-specific, were assessed in the cohort of patient samples. The mitochondrial PCR products were sequenced in both directions.

Among the 135 samples assayed, 28 were defined as malaria positive by at least two of the methods among microscopy and the three different genus-specific PCR assays. The new mitochondrial PCR was 100% sensitive detecting all 28 positives. At the threshold dilution 0.5 parasites/µL, the sensitivity of the mitochondrial PCR was 97%, that of the single-round, 18S PCR was 93%, and the reference nested 18S was PCR 87%. Both single-round amplification assays identified all malaria positives diagnosed by nested PCR that had a sensitivity of 96%.

Sequencing of the genus-specific mitochondrial PCR products revealed different single nucleotide polymorphisms that allowed species identification of the 28 sequences with following distribution; 20 were Plasmodium falciparum, 6 were P. vivax, 1 was P. ovale, and 1 P. malariae. The microscopists had missed two infections detected by all PCR assays.

The authors concluded that the design of PCR programs with suitable parameters and optimization resulted in simpler and faster single-round amplification assays. Both the sensitivity and specificity of the novel mitochondrial PCR was 100% and proved equivalent to the reference nested PCR. Sequencing of genus-specific mitochondrial PCR products could be used for species determination. The study was published on January 22, 2013, in the Malaria Journal.

Related Links:

Haukeland University Hospital


New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Dehydroepiandrosterone Assay
DHEA ELISA
New
Basophil Activation Test
Flow CAST Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.